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Abstract
Background: Patients with major depressive disorder have a higher prevalence and incidence of dyslipidemia.
However, clinical studies concerning the association between lipid levels and depression are inconsistent.
Adipokines (like leptin and adiponectin) and ghrelin are strongly associated with lipid metabolism. Fish oil, which is
reported to possess antidepressant effect, also have beneficial effects on lipid metabolism and the cardiovascular
system. In the present study, we investigated lipid metabolism in rats exposed to chronic unpredictable mild stress
(CUMS) and the effect of fish oil on lipid profiles, aforementioned adipokines and ghrelin.
Methods: Sucrose preference test (SPT), open field test (OFT) and forced swimming test (FST) were used to
evaluate the antidepressant-like effects of fish oil. After the behavior tests, peripheral blood were collected. Serum
parameters, including fasting triglyceride (TG), total cholesterol (TCH), high density lipoprotein-cholesterol (HDL-c),
low density lipoprotein-cholesterol (LDL-c), free fatty acid (FFA), glucose (GLU), adipokines (leptin, adiponectin) and
ghrelin were assayed.
Results: After 5 weeks of CUMS procedures, rats were induced to depressive-like state, and exhibited increased
serum levels of TCH, HDL-c, FFA and decreased serum levels of leptin and ghrelin, whereas the serum status of
adiponectin, GLU, TG and LDL-c remained stable. Fish oil treatment showed robust antidepressant effect and
reversed the stress-induced lipid disturbance and decrease in serum concentration of ghrelin.
Conclusions: Our results suggested that CUMS altered the serum levels of lipid profiles, leptin and ghrelin in rats.
Fish oil supplementation not only provided antidepressant-like effects, but also reversed the altered lipid profiles
and ghrelin level in serum. Our data indicated that fish oil treatment exerts anti-depressant effect and regulates
lipid disturbance simultaneously.
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Background
Dyslipidemia and obesity have been observed in people
with severe depression or in patients treated with tricyclic
antidepressants [1], which are likely to contribute to the
higher risk of cardiovascular disease (CVD). Sertraline, the
selective serotonin reuptake inhibitor, is a classic and ef-
fective antidepressant and is well tolerated in patients with
depression comorbid cardiovascular disease [2]. Well-
documented evidence has shown that fish oil possesses
antidepressant effect both on human and animals [3, 4].
Moreover, fish oil has been shown to reduce obesity and
to have beneficial effects on lipid metabolism [5].
Recent clinical studies indicated that patients with
depression are prone to have undesirable lipid profiles i.e.
higher levels of triglyceride (TG), total cholesterol (TCH),
low density lipoprotein-cholesterol (LDL-c), free fatty acid
(FFA) and lower level of high density lipoprotein-
cholesterol (HDL-c) than normal controls [6–8]. However,
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clinical studies concerning the relationship between lipid
levels and depression have yielded inconsistent results [6].
To avoid the clinical interference factors, the present
study was conducted in chronic unpredictable mild stress
(CUMS) rats, a valid animal model of depression [9], to
investigate the alteration of lipid metabolism in the
affective disorder.
Recent findings have shown that adipocyte-derived
hormone, leptin and adiponectin, and the gut hormone,
grehlin play critical roles in energetic homeostasis, insulin
sensitivity and lipid metabolism [10–12]. Interestingly,
they also have important effects in the central nervous
system and mood [13]. Namely, depression was highly as-
sociated with altered adipokines and ghrelin. Meanwhile,
administration of exogenous adipokines or ghrelin pre-
sented an antidepressant effects [14–17]. However, the
evidence concerning the interrelationship among leptin,
adiponectin, ghrelin and depression is still limited and
controversial [18]. Moreover, accumulating evidence sug-
gested that fish oil administration could stimulate the
serum levels of leptin, adiponectin and ghrelin [19, 20].
Therefore, the present study was carried out to investigate
lipid metabolism in rats exposed to chronic unpredictable
mild stress (CUMS) and the effect of fish oil on lipid
profiles, aforementioned adipokines and ghrelin.
Methods
Animals
Male Sprague–Dawley rats, weighing 150–180 g (week 8),
were initially housed in groups of three in a temperature-
controlled environment under a 12-h light/dark cycle,
with ad libitum access to food and water except during
experimental procedures. All animal use procedures were
conducted according to the Regulations of Experimental
Animal Administration issued by the State Committee of
Science and Technology of the People’s Republic of China,
with the approval of the Ethics Committee in The Experi-
mental Animal Center of the Second Xiangya Hospital.
Drug treatment and CUMS procedures
Rats were randomly assigned to six groups (n = 9): (1)
control, (2) control + FO, (3) control + ser, (4) CUMS,
(5) CUMS + FO, (6) CUMS + ser. Fish oil (FO, EPA34 %,
DHA24 %, Sheng Tianyu Biotechnology co., China) and
sertraline (ser, Eastbang Pharmaceuticals, China) were
dissolved in sterile saline containing 0.5 % Tween [21].
We use sertraline as positive control for behavior test of
rats. The FO supplementary groups received daily gavage
of 1.5 g/kg fish oil 2 weeks before the CUMS procedures
started, until the end of the experiments. The sertraline
groups received daily gavage of 8 mg/kg sertraline at day
1 when the CUMS procedures started [22], while the
control and CUMS groups received same volume of
saline containing 0.5 % Tween.
The CUMS procedures were performed as described
previously with minor modifications [12]. This paradigm
was designed to maximize unpredictability and mildness
of the stress intensity. The rats of CUMS groups were
housed in a separate cage (cage size: 26 × 19 × 15 cm),
while others share one cage (three per cage, cage size:
90 × 45 × 25 cm). After acclimatized to the laboratories for
5 days, and 2 weeks gavage of fish oil or saline respect-
ively, the CUMS groups received random unpredictable
stress for 5 consecutive weeks (Fig. 1). Stress stimuli in-
cluded: cage tilting for 24 h; damp bedding for 24 h; fast-
ing for 24 h; water deprivation for 24 h, finally with 1 h an
empty bottle; light–dark-cycle reversal (12 h/12 h), behav-
ior restriction for 2 h; 30 min noise, 5 min tail pinch. Rats
received one of these stressors per day and same stressor
was not applied in 2 consecutive days. The rats were
weighed every 3 days and the dose was adjusted to its
weight gain. All animals were subjected to three behav-
ioral tests to confirm induction of depression-like behav-
iors in CUMS rats as described below.
Sucrose preference test
Anhedonia, which is a central feature of depression, was
defined as a reduction in sucrose preference [23]. Briefly,
Fig. 1 Timeline of experimental procedures
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rats were placed in individual cages for habituation to the
sucrose solution (1 %, w/v): two bottles of 1 % sucrose so-
lution were placed in the cage for the first 32 h, then after
16 h water deprivation, one bottle of 1 % sucrose solution
was replaced with water for 1 h. The rats were permitted
free access to the two bottles. The volumes of consumed
sucrose solution and water were recorded. Completing
this period, the liquid consumption was measured and the
sucrose liquid drinking volume, as a percentage of the
total liquid consumption, was calculated.
Open field test
For the open field test, spontaneous locomotor activity was
measured as described previously [22], with minor modifi-
cations. Reduced number of locomotor crossing and rear-
ing reflected the loss of interest, a hallmark of depression,
in rodents [24]. Briefly, the test chamber consisted of a
square arena (90 cm× 90 cm× 40 cm). The floor was di-
vided into 25 equal squares by black lines. At the beginning
of the test, the animal was placed in the center of the arena
and allowed to freely explore for 5 min. The apparatus was
cleaned with 75 % ethanol after each testing session to pre-
vent any odors deposited by the rats from influencing the
following rat. The horizontal locomotor activities (segments
crossed with all four paws) and vertical exploratory activ-
ities (standing on their hind paws) were scored.
Forced swimming test
FST is widely used for measurement of depression-like
behavior in rodents. Briefly, each rat was placed in a
plastic drum (45 cm height, 25 cm diameter) containing
approximately 35 cm of water (24 ± 1 °C) for a 15-min
pretest. Twenty-four hours later, the rat was exposed to
the same experimental conditions outlined above for a
5-min FST. Each test session was videotaped and the
duration of immobility, which defined as floating pas-
sively and only making slight movements to keep the
head above water, was scored by an experienced obser-
ver blind to the experiment design.
Serum parameters
Upon completion of the experiments, all rats were
weighed and blood was collected from the anesthetized
animals into blood collection tubes after a 12-h overnight
fast. After standing for 30 min, the serum was prepared by
centrifugation of blood at 1000 × g for 10 min at 4 °C and
stored at −80 °C until analysis. Serum levels of triglyceride
(TG), total cholesterol (TCH), high density lipoprotein-
cholesterol (HDL-c), low density lipoprotein-cholesterol
(LDL-c), free fatty acid (FFA) and glucose (GLU) were
measured by means of enzymatic methods, using assay
kits (Sekisui Medic; Abbott Laboratories or Beijing lead-
man biochemistry co., LTD). Enzyme-linked immunosorb-
ent assays were used to measure the serum levels of leptin
(R&D systems, USA), ghrelin (RayBiotech, USA) and adi-
ponectin (CUSABIO Biotech, Ltd).
Statistical analysis
Results were expressed as mean ± SEM. Statistical ana-
lyses were performed with one-way analysis of variance
(ANOVA) for multiple comparisons followed by TUKEY
for post-hoc test. The prior level of significance was
established at P < 0.05.
Results
Body weight gain and behavioral test
As shown in Table 1. After 5 weeks of CUMS proce-
dures, the body weight of CUMS rats was significantly
lower than the control (P < 0.01). Treatment of fish oil or
sertraline before the establishment of CUMS model failed
to restore this change. The CUMS rats showed reduced
sucrose preference (P < 0.01) in the sucrose preference test
(SPT), decreased locomotor crossing (P < 0.01) and rearing
(P < 0.01) activity in the open field test (OFT) and increased
immobility times (P < 0.05) in the forced swim test (FST).
As an effective antidepressant and positive control in our
study, sertraline administration improved the decreased su-
crose preference in CUMS rats (P < 0.05). Compared with
CUMS group, decreased sucrose preference was also re-
versed by supplementation of fish oil (P < 0.05). In addition,
Table 1 Changes in body weight and behavioral test
Groups Body weight (g) % Sucrose preference OFT Immobility time ( s )
Number of crossing Number of rearing
con 357.50 ± 10.00 88.06 ± 3.24 36.71 ± 3.55 15.25 ± 2.15 62.09 ± 6.52
con + FO 361.25 ± 11.29 79.24 ± 3.87 33.21 ± 3.66 15.31 ± 2.52 56.02 + 10.28
con + ser 351.11 ± 14.28 85.42 ± 3.65 40.41 ± 3.29 14.67 ± 1.70 39.00 ± 7.64
CUMS 319.44 ± 11.74** 46.79 ± 3.35** 11.25 ± 4.46** 8.17 ± 2.22* 101.52 ± 11.43*
CUMS + FO 301.88 ± 7.32 77.01 ± 3.60## 35.91 ± 4.02## 12.64 ± 2.47 47.33 ± 9.87##
CUMS + ser 318.13 ± 8.76 72.46 ± 4.38## 37.92 ± 4.75## 15.63 ± 1.80# 55.92 ± 7.21##
Data are expressed as means ± SEM (n = 8)
CUMS chronic unpredictable mild stress, con control, FO fish oil, ser sertraline
*P < 0.05, **P < 0.01 compared to control group. #P < 0.05, ##P < 0.01 compared to CUMS group
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the animals in sertraline treatment group showed more
numbers of crossing (P < 0.01) and rearing (P < 0.05), but
fish oil treatment only had significant effect on number of
crossing (P < 0.01). Post hoc tests indicated that fish oil
(P < 0.01) treatment reversed the CUMS-induced decrease
in immobility time.
Serum lipid profiles
One day after the behavior tests, peripheral blood was col-
lected. As shown in Fig. 2, CUMS significantly increased
the serum levels of TCH (P < 0.05), HDL-c (P < 0.01) and
FFA (P < 0.05), whereas TG and LDL-c remained stable.
Fish oil supplementation restored CUMS-induced increase
of serum TCH (P < 0.05) HDL-c (P < 0.05), FFA (P < 0.05),
but sertraline treatment had no effect on TCH and HDL-c
and signicantly increased the serum level of FFA both in
control (P < 0.01) and CUMS (P < 0.05) rats. Meanwhile,
the level of TG was significantly decreased by the treatment
of fish oil (P < 0.01) and sertraline (P < 0.01) in CUMS rats.
Serum levels of adipokines and ghrelin
As shown in Fig. 3a, the serum level of leptin was signifi-
cantly down-regulated in rats that exposed to CUMS (P <
0.01), whereas fish oil or sertraline treatment failed to re-
verse this change. Meanwhile, both chronic stress and an-
tidepressants administration had no effect on serum level
of adiponectin in rats. Interestingly, we found a significant
decrease of ghrelin level in CUMS rats (Fig. 3c, P < 0.05),
whereas this reduction was restored to normal by supple-
mentation of fish oil (P < 0.05) or sertraline (P < 0.05).
Discussion
In the present study, CUMS, a valid model of depression
for rodents, was established. The pathophysiology of
Fig. 2 Serum levels of lipid profiles and glucose. (A) Concentration of TG; (B) Concentration of TCH; (C) Concentration of HDL-c; (D) Concentration of
LDL-c; (E) Concentration of FFA; (F) Concentration of GLU. Data are expressed as means ± SEM (n = 8).*P < 0.05, **P < 0.01 compared to control group.
#P < 0.05, ##P < 0.01 compared to CUMS group
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depression might be related to the alterations in the lipid
profiles. Animal study showed that CUMS increased
plasma HDL-c significantly [25], which is different from
clinical studies. Though the causes may be complicated,
the discrepancy is greatly due to species specific effects.
Additionally, HDLs are a class of heterogeneous lipopro-
teins. Different HDL subpopulations have distinct and
characteristic functions, which means HDL subpopula-
tion levels are better predictors than HDL-c levels [26].
Further studies concerning on the subpopulation levels
of HDLs are needed. It has been reported that treatment
with antidepressants significantly decreased both serum
TCH and HDL-c levels in patients with major depres-
sion or affective disorders [6]. Elevated FFA had an ad-
verse effect on body, causing damage to the pancreatic
beta cell function, promoting cell apoptosis, and result-
ing in impaired glucose-stimulated insulin secretion
[27]. Fish oil supplementation, an auxiliary treatment for
depression, was reported to reduce the serum levels of
TCH and regulate HDL-c composition and metabolism
[28, 29]. In parallel with previous evidence, CUMS in-
creased the serum levels of TCH, HDL-c and FFA,
which reflected the dyslipidemia in CUMS rats. Interest-
ingly, fish oil supplementation reversed these changes
and improved the dysfunctional of lipids metabolism.
On the contrary, sertraline administration failed to re-
verse the serum levels of TCH and HDL-c and further
elevated serum concentration of FFA. It’s worth men-
tioning that diabetes mellitus is now perceived as an im-
portant comorbid condition in patients with depression
[30]. Stress-induced increase in FFA level may partly ex-
plain the comorbid depression and diabetes. There is
considerable evidence suggests that TG play a role in ad-
verse health conditions like metabolic syndrome (MetS)
[31]. Fish oil was found to reduce the serum level of TG
level both in human and mice [29, 32]. Similar to the
previous study, fish oil or sertraline administration in
CUMS groups decreased the serum level of TG. We
have observed that excessive fish oil intake may signifi-
cantly lower the serum lipids, and prevent the disturb-
ance of lipid metabolism, but the effect of sertraline on
lipid regulation is mild and even deteriorated. Fish oil
might be an excellent replacement therapy in depression
for its beneficial effects on the progression of both
depression and dyslipidemia.
Adipokines, like leptin and adiponectin, are well known
for their roles in energy homeostasis [12]. Recently, accu-
mulated studies have demonstrated the negative relation-
ships between leptin level and severity of symptoms of
depression in human [33]. Animal studies also showed that
various chronic stress [15, 33–35] significantly decreased
the serum concentration of leptin. Although leptin insuffi-
ciency might be associated with depression-like behavior,
and leptin had antidepressant-like efficacy in rats exposed
to chronic stress [15], most clinical data indicated that anti-
depressant medications, such as fluxetine, imipramine, par-
oxetine and venlafaxine had no effect on leptin level [16].
In the present study, the serum level of leptin was signifi-
cantly down-regulated in rats exposed to CUMS. Similar to
the previous studies using various antidepressants, fish oil
or sertraline supplementation also failed to reverse leptin
level. Chronic social-defeat stress was reported to reduce
the plasma level of adiponectin, and administration of ex-
ogenous adiponectin produced antidepressant-like behav-
ioral effects in mice [14]. Some reports showed higher
serum concentration of adiponectin in MDD subjects com-
pared to healthy controls [36], while other investigators
found either lower levels [11, 37] or unaltered [38, 39] per-
ipheral adiponectin levels in MDD individuals versus con-
trols. In the present study, both chronic stress and
antidepressants supplementary had no effect on serum con-
centration of adiponectin in rats. Ghrelin, a gut hormone,
had an orexigenic effect on appetite and energy balance.
Recent study suggested that serum level of ghrelin was
Fig. 3 Serum levels of leptin, adiponectin and ghrelin. (A) Concentration of serum leptin; (B) Concentration of serum adiponectin; (C) Concentration
of serum ghrelin. Data are expressed as means ± SEM (n = 8).*P < 0.05, **P < 0.01 compared to control group. #P < 0.05 compared to CUMS group
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decreased in patients with depression [16]. A subgroup of
healthy volunteers who received a single intravenous injec-
tion of ghrelin after an overnight fast developed elevated
mood [17]. Activation of ghrelin signaling was also reported
to produce antidepressant-like response in mice [40]. In the
present study, we found a significant decrease of ghrelin
level in CUMS rats, whereas this reduction was restored by
supplementation of fish oil or sertraline. These findings in-
dicated that decreased leptin and ghrelin levels might show
an important role in the chronic stress-induced depression.
Fish oil treatment might play an antidepressant effect
through increasing the serum concentration of ghrelin, the
similar mechanism to sertraline, providing a potential target
for treatment of depression.
Conclusions
The main novel finding of the present study were as
follows: 1) chronic stress could alter the lipid profiles,
leptin and ghrelin of rats; 2) treatment with fish oil not
only provided antidepressant-like effects, but also re-
versed disturbance of lipid metabolism and restored the
serum status of ghrelin in CUMS rats, whereas sertraline
could only reverse the alerted ghrelin. Since sertraline
have mild effect on or even aggravate the dyslipidemia
in CUMS rats, which contributes to the higher risk of
CVD, fish oil treatment might be an effective auxiliary
treatment for patients with depression.
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